Elicio Therapeutics, Inc.
ELTX
$8.19
-$0.19-2.21%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 20.61M | 22.09M | 18.35M | 17.62M | 26.02M |
| Total Receivables | -- | -- | -- | -- | 2.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 616.00K | 304.00K | 1.60M | 1.65M | 3.08M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 238.00K | 206.00K | 980.00K | 1.42M | 1.55M |
| Total Current Assets | 21.47M | 22.60M | 20.94M | 20.69M | 30.65M |
|
|
|||||
| Total Current Assets | 21.47M | 22.60M | 20.94M | 20.69M | 30.65M |
| Net Property, Plant & Equipment | 5.35M | 5.63M | 5.91M | 6.19M | 6.45M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.47M | 1.30M | 1.30M | 1.30M | 1.29M |
| Total Assets | 28.28M | 29.53M | 28.14M | 28.18M | 38.39M |
|
|
|||||
| Total Accounts Payable | 321.00K | 3.87M | 4.04M | 1.04M | 1.98M |
| Total Accrued Expenses | 5.21M | 5.11M | 5.77M | 8.42M | 4.85M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 981.00K | 952.00K | 926.00K | 901.00K | 877.00K |
| Total Finance Division Other Current Liabilities | -- | -- | 680.00K | 1.17M | 1.31M |
| Total Other Current Liabilities | -- | -- | 680.00K | 1.17M | 1.31M |
| Total Current Liabilities | 6.52M | 9.92M | 11.41M | 11.52M | 9.02M |
|
|
|||||
| Total Current Liabilities | 6.52M | 9.92M | 11.41M | 11.52M | 9.02M |
| Long-Term Debt | 9.72M | 9.34M | -- | 20.03M | 19.84M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 4.36M | 4.61M | 4.87M | 5.11M | 5.34M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 3.88M | 3.82M | 2.96M | 2.83M | 23.18M |
| Total Liabilities | 24.47M | 27.69M | 19.24M | 39.49M | 57.37M |
|
|
|||||
| Common Stock & APIC | 229.95M | 217.93M | 214.51M | 183.11M | 161.46M |
| Retained Earnings | -225.95M | -215.87M | -205.31M | -194.10M | -180.10M |
| Treasury Stock & Other | -181.00K | -220.00K | -294.00K | -325.00K | -352.00K |
| Total Common Equity | 3.82M | 1.83M | 8.90M | -11.31M | -18.99M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 3.82M | 1.83M | 8.90M | -11.31M | -18.99M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 3.82M | 1.83M | 8.90M | -11.31M | -18.99M |
|
|
|||||